BRIDGEWATER, N.J., May 13, 2014 /PRNewswire/ -- Professional football icon Jerome Bettis, the Asthma and Allergy Foundation of America (AAFA) and Sanofi US, the makers of Auvi-Q ® (epinephrine injection, USP), are asking What's Your AQ? in an effort to help improve America's understanding of severe, life-threatening allergic reactions (anaphylaxis) and to help clear up some common misconceptions. Bettis, who is severely allergic to shellfish, is challenging people to test their AQ, or Anaphylaxis Quotient, by taking the What's Your AQ? quiz.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/7143251-sanofi-us-jerome-bettis-allergy-foundation-launch-severe-allergies-quiz
Developed with insights from AAFA and other members of the anaphylaxis community, the quiz was created to help people find answers to recurring questions around severe, life-threatening allergies including how to avoid allergens, recognize symptoms and treat anaphylaxis.
"From our daily interactions with adults and children who are at risk for anaphylaxis, including parents, caregivers, the newly diagnosed and long-time patients, it's clear there is a need for continued education," said Mike Tringale, Senior Vice President at AAFA. "The right knowledge can be life-saving, and the What's Your AQ? quiz is a new and engaging way to help everyone learn more about preventing anaphylaxis and learn more about being prepared in the event of an emergency."According to "Anaphylaxis in America", a 2011 landmark survey of 1,000 adults sponsored by Sanofi US, as many as 1 in 20 adult Americans is at risk for anaphylaxis. This is why avoiding allergens and being prepared are important considering a reaction can happen quickly and can cause death in minutes. "I was diagnosed with my severe allergy more than 27 years ago and while I always considered myself knowledgeable about my condition, I realized even after all these years there's always more to learn," said Bettis, who is once again teaming up with Sanofi US to promote anaphylaxis awareness. "As an example, when I first began working with Sanofi, I learned the importance of making sure I always carry two Auvi-Q epinephrine auto-injector devices with me at all times."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts